Search Results for 'advanced'

Filter results by..

Type

All (17)

Briefing (2)

Webpage (15)

Pancreatic cancer is often diagnosed at an advanced stage as most symptoms may not be evident while the tumour is small and localised. This is one of the major reasons that survival rates are low. This data briefing aims to present a comparison of survival between the constituent countries of Great Britain: England, Wales and Scotland in three time periods (1995-1999, 2000-2004, 2005-2009).
Prostate cancer survival is related to stage at diagnosis. The relative survival for men with advanced and metastatic tumours is markedly worse than for localised tumours. Survival is best for men aged 60-69 at diagnosis. Data briefing prepared by South West Public Health Observatory.
Non-transitional-cell-carcinomas make up 1 in 6 bladder cancers. They have a much worse survival, which may reflect differences in aetiology, treatment or degree of advanced disease at presentation.
Pancreatic cancer is often diagnosed at an advanced stage as most symptoms may not be evident while the tumour is small and localised. This is one of the major reasons that survival rates are low. This data briefing aims to present a comparison of survival between the constituent countries of Great Britain: England, Wales and Scotland in three time periods (1995-1999, 2000-2004, 2005-2009).
KEY MESSAGE: For women with ovarian cancer, mortality is high in the first two months after diagnosis. Mortality is particularly high among elderly patients and those diagnosed via an emergency presentation route. Women with combinations of these major risk factors have even higher mortality.
Details of the members of the colorectal cancer SSCRG.
The rates of women dying from ovarian cancer in England has fallen from 11.2 women in every 100,000 (3,820 cases) in 2001 to 8.8 per 100,000 (3,453 cases) in 2010 – a drop of around 20 per cent, according to a new report by the National Cancer Intelligence Network published, today (Tuesday 21st).
Building on previous work that showed a particularly high mortality rate in the first month or two after diagnosis, this analysis considered the association between excess mortality rates and relevant patient and tumour factors in three periods within the first year after diagnosis of ovarian cancer in England.
National Cancer Registration and Analysis Service and Transforming Cancer Services Team for London Partnership webpage
Between 2007 and 2009 there were an average of 7,800 uterine cancer cases diagnosed annually in the UK, making this the fourth most common cancer in women and the most common gynaecological cancer. Between 2008 and 2010, there were an average of just over 1,800 deaths from uterine cancer. This makes uterine cancer the ninth most common cause of cancer death in women in the UK and the second most common gynaecological cancer death after ovarian cancer.
1  2